Glaxosmithkline Us Trading Limited is a liquidation company incorporated on 12 September 2018 with the registered office located in Liverpool, Merseyside. Glaxosmithkline Us Trading Limited was registered 7 years ago.
Registered office address changed from 79 New Oxford Street London WC1A 1DG United Kingdom to C/O Bdo Llp, 5 Temple Square Temple Street Liverpool L2 5RH on 6 January 2026
Submitted on 6 Jan 2026
Appointment of a voluntary liquidator
Submitted on 6 Jan 2026
Resolutions
Submitted on 6 Jan 2026
Declaration of solvency
Submitted on 6 Jan 2026
Solvency Statement dated 05/11/25
Submitted on 10 Nov 2025
Statement of capital on 10 November 2025
Submitted on 10 Nov 2025
Resolutions
Submitted on 10 Nov 2025
Statement by Directors
Submitted on 10 Nov 2025
Confirmation statement made on 29 September 2025 with no updates
Submitted on 29 Sep 2025
Termination of appointment of Andrew James Collier as a director on 11 August 2025